Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wed, 02 Apr 2014 12:08:00 GMT ~ Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO [GlobeNewswire] - PETALUMA, Calif. -- Oculus Innovative Sciences, Inc. , today announced the closing of its subsidiary, Ruthigen, Inc.'s , initial public offering on the NASDAQ Capital Market on March 26, 2014. As part ... read full: http://finance.yahoo.com/news/oculus-innovative-sciences-announces-board-120800870.html *********************************************************
Mon, 31 Mar 2014 20:19:47 GMT ~ RUTHIGEN, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Fin read full: http://biz.yahoo.com/e/140331/rtgn8-k.html *********************************************************
Fri, 21 Mar 2014 13:39:00 GMT ~ Ruthigen Announces Pricing of Initial Public Offering [PR Newswire] - SANTA ROSA, Calif., March 21, 2014 /PRNewswire/ -- Ruthigen, Inc., (RTGN), a biopharmaceutical company focused on the discovery, development and commercialization of pharmaceutical-grade hypochlorous acid, or HOCl, based therapeutics designed to prevent and treat infection in invasive applications, today announced the pricing of its initial public offering of 2,650,000 units, which reflects an increase in the originally anticipated number of units, with each unit consisting of one share of common stock and one Series A Warrant. Each Series A Warrant is exercisable for one share of common stock and one Series B Warrant to purchase one share of common stock. All of the units are being offered by Ruthigen at an initial public offering price of $7.25 per unit. The units will not be certificated and the shares of common stock and Series A Warrants may be transferred separately immediately upon issuance. In addition, Ruthigen has granted the representative of the underwriters a 45-day option to purchase up to 397,500 additional shares of common stock, and/or 397,500 additional Series A Warrants, or any combination thereof. The shares of the Company's common stock are expected to begin trading on The NASDAQ Capital Market on Friday, March 21, 2014 under the trading symbol "RTGN." The offering is expected to close on March 26, 2014, subject to customary closing conditions. read full: http://finance.yahoo.com/news/ruthigen-announces-pricing-initial-public-133900322.html *********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RTGN/company-info Ticker: $RTGN OTC Market Place: Not Available CIK code: not found Company name: Ruthigen, Inc. Incorporated In: